Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF for Prevention of Mother-to-child Transmission of Hepatitis B
NCT02995005Phase 2Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- May 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenofovir disoproxil fumarate in hepatitis B (HBV), sponsored by Johns Hopkins Bloomberg School of Public Health. Started May 2018; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02995005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02995005.